Report by
Recall notice
Himalayan Tea - recalled due to undeclared Diclofenac and Dexamethasone
2 years ago •source fda.gov
United States
WS Global, INC Brooklyn, NY is voluntarily recalling all lots of Himalayan Pain Relief Tea, tea packets to the consumer level. The products have been found to contain undeclared drugs, Diclofenac and Dexamethasone. This product was distributed Nationwide through Amazon (internet) and online only. To date, WS Global Inc., has not received any reports of adverse events related to this recall.Diclofenac is a non-steroidal anti-inflammatory drug (commonly referred to as NSAIDs). NSAIDs may cause increased risk of cardiovascular events, such as heart attack and stroke, as well as serious gastrointestinal damage, including bleeding, ulceration, and fatal perforation of the stomach and intestines. This hidden drug ingredient may also interact with other medications and significantly increase the risk of adverse events, particularly when consumers use multiple NSAID-containing products.
Dexamethasone is a corticosteroid commonly used to treat inflammatory conditions. Corticosteroid use can impair a person's ability to fight infections and can cause high blood sugar levels, muscle injuries, and psychiatric problems. When corticosteroids are taken for a prolonged period, or at high doses, they can suppress the adrenal gland. Only licensed healthcare professionals can evaluate patients for the risk or existence of adrenal suppression. In addition, the undeclared dexamethasone in Himalayan Pain Relief Tea may cause serious side effects when combined with other medications.
The product is used as tea and is packaged in a light-yellow box containing 6 tea packets, printed with barcode 0841920015. The affected Himalayan Pain Relief Tea lots include the following "ALL LOTS".
Consumers taking Himalayan Pain Relief Tea should immediately consult their health care professional to safely discontinue the use of this product. The risks of withdrawal from corticosteroids should be assessed by a healthcare professional. Abrupt discontinuation can cause withdrawal symptoms.
Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
Company name: WS Global, Inc.
Brand name: Himalayan
Product recalled: Tea
Reason of the recall: Undeclared drugs, Diclofenac and Dexamethasone
FDA Recall date: December 13, 2023
Source: www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ws-global-issues-nationwide-recall-himalayan-pain-relief-tea-due-presence-hidden-drug-ingredients
312
Comments
Comment
